Kurtz Matthew M, Baker Elizabeth, Pearlson Godfrey D, Astur Robert S
Schizophrenia Rehabilitation Program, Institute of Living, 200 Retreat Avenue, Hartford, CT 06106, USA.
Schizophr Bull. 2007 Sep;33(5):1162-70. doi: 10.1093/schbul/sbl039. Epub 2006 Sep 6.
Performance on a novel, virtual reality (VR) assessment of medication management skills, the Virtual Reality Apartment Medication Management Assessment (VRAMMA), was investigated in 25 patients with schizophrenia and 18 matched healthy controls. The VRAMMA is a virtual 4-room apartment consisting of a living room with an interactive clock and TV, a bedroom, a kitchen, and a bathroom with an interactive medicine cabinet. After an exploratory phase, participants were given a mock prescription regimen to be taken 15 minutes later from pill bottles located in the medicine cabinet in the bathroom of the virtual environment. The VRAMMA was administered with a validated measure of medication management skills, several neurocognitive tests, and a symptom scale. Results revealed that (1) schizophrenic patients made significantly more quantitative errors in the number of pills taken, were less accurate at taking the prescribed medications at the designated time, and checked the interactive clock less frequently than healthy controls; (2) in patients with schizophrenia, there was significant agreement in classification of adherence vs nonadherence between a validated measure of medication management skills and the VRAMMA; and (3) in patients with schizophrenia, years of education and a measure of verbal learning and memory were linked to quantitative errors on the VRAMMA, while positive symptoms, specifically delusional symptoms, were inversely linked to distance traveled within the VRAMMA. This is the first study, to our knowledge, to provide evidence for the utility of VR technology in the assessment of instrumental role functioning in patients with schizophrenia.
对25名精神分裂症患者和18名匹配的健康对照者进行了一项关于药物管理技能的新型虚拟现实(VR)评估——虚拟现实公寓药物管理评估(VRAMMA)。VRAMMA是一个虚拟的四居室公寓,包括一个带有交互式时钟和电视的客厅、一间卧室、一个厨房以及一个带有交互式药柜的浴室。在探索阶段之后,参与者被给予一个模拟处方方案,要求在15分钟后从虚拟环境中浴室药柜里的药瓶中取药。VRAMMA与一项经过验证的药物管理技能测量方法、多项神经认知测试以及一个症状量表一同进行。结果显示:(1)精神分裂症患者在服药数量上出现的定量错误显著更多,在指定时间服用规定药物的准确性更低,且查看交互式时钟的频率低于健康对照者;(2)在精神分裂症患者中,经过验证的药物管理技能测量方法与VRAMMA在依从性与非依从性分类上存在显著一致性;(3)在精神分裂症患者中,受教育年限以及一项言语学习和记忆测量指标与VRAMMA上的定量错误有关,而阳性症状,特别是妄想症状,与VRAMMA内的行进距离呈负相关。据我们所知,这是第一项为VR技术在评估精神分裂症患者工具性角色功能方面的效用提供证据的研究。